Bioinformatics Markets for Next-Generation Sequencing

 
   Single User - $1,500
   Site License (one location, 10 users) - $2,250
   Corporate License - $3,000



Loading...
Published Jun 23, 2017 | 96 Pages | Pub ID: KLI15394112

Bioinformatics Markets for Next-Generation Sequencing

There is an inseparable connection between next-generation sequencing and information technology.  Next generation sequencing platforms rapidly generate very high volumes of complex data.  The speed at which they do this has a great number of benefits, but comes at a price: the quickly-produced data must be checked and reformatted to be useful.   This creates a great demand for software that can handle these processes.   

This report examines the important contribution made by information technology to the use of next-generation sequencing, and to the markets for  systems and consumables.  It attempts to define market contributions for software components, and describes in detail the competitors that are involved in this market. 

The Use of Bioinformatics in Next-Generation Sequencing, and the Market Opportunity

As part of its coverage, the report provides the following:
  • Products on the Market and In Development
  • Bioinformatics Market for NGS, 2016 and 2021
  • Software Segment, 2016 and 2021
  • Hardware Segment, 2016 and 2021
  • Services Segment, 2016 and 2021
  • Indirect Market for Bioinformatics (Including Influence on Overall NGS Market)
  • Trends
  • Company Activities Relating to NGS Bioinformatics
  • Company Profiles
  • Sequencing Market 2017
This report looks at the market for bioinformatics systems that can assist in storing, handling, interpreting and assembling data originally from next-generation sequencers.  The report does not include sample preparation or target enrichment products, though Kalorama Information publishes other reports in this area.  

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications.  The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Companies Discussed Include:

  • Advanced Biological Laboratories, S,A,
  • Appistry, Inc.
  • Apple
  • AstridBio Technologies Inc. 
  • Advaita Bioinformatics
  • Bina Technologies, Inc.
  • BioDiscovery, Inc.
  • Biomatters Ltd.
  • Bluebee
  • Cerner
  • CLC bio (A Qiagen Company)
  • Congenica
  • Cypher Genomics
  • Desktop Genetics 
  • Diploid
  • DNASTAR, Inc.
  • DNA Nexus
  • Edico Genome
  • Gataca
  • Genalice 
  • GeneInsight, Inc. (A Sunquest Company)
  • GenoLogics (An Illumina company)
  • Genomatix Software Gmbh
  • Genome International Corporation (GIC)
  • Genomeon LLC
  • Genomocology  
  • Golden Helix
  • Google
  •  IBM
  • IDbyDNA, Inc.,
  • Igenbio, Inc.
  • Illumina, Inc.
  • Kapa Biosystems
  • Knome
  • Lumenogix Inc.
  • Maverix Biomics Inc.
  • Natera, Inc. 
  • NetLIMS
  • N-of-One, Inc.
  • NSilico Lifescience Ltd.
  • Omicia
  • Perkin Elmer
  • Personal Genome Diagnostics
  • PierianDx
  • QIAGEN N.V.
  • Real Time Genomics
  • Sapio Sciences
  • SoftGenetics, LLC
  • SOPHiA Genetics
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics (VelaDx)
  • WuXi NextCODE

In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.